Edition:
United States

Evotec AG (EVTG.DE)

EVTG.DE on Xetra

10.72EUR
28 Apr 2017
Change (% chg)

€0.09 (+0.85%)
Prev Close
€10.62
Open
€10.57
Day's High
€10.79
Day's Low
€10.57
Volume
747,171
Avg. Vol
1,189,605
52-wk High
€10.79
52-wk Low
€3.10

EVTG.DE

Chart for EVTG.DE

About

Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees,... (more)

Overall

Beta: 0.82
Market Cap(Mil.): €1,557.30
Shares Outstanding(Mil.): 146.57
Dividend: --
Yield (%): --

Financials

  EVTG.DE Industry Sector
P/E (TTM): 51.19 58.07 30.12
EPS (TTM): 0.21 -- --
ROI: 10.57 0.23 13.28
ROE: 13.82 6.18 14.44

BRIEF-Evotec achieves first milestone in diabetes alliance with Sanofi

* Says achieves first milestone in diabetes alliance with sanofi

Apr 05 2017

BRIEF-Evotec sees significant improvement in 2017 core profit

* 2016 stable group research and development expenses of 18.1 mln eur

Mar 28 2017

BRIEF-Novo A/S has no plans to buy more Evotec shares

* Novo A/S does not intend to obtain further voting rights by acquisition or any other way

Mar 15 2017

Denmark's Novo raises holding in Evotec to 10.1 pct

FRANKFURT, Feb 28 Denmark's Novo A/S has increased its holding in German biotech group Evotec AG to more than 10 percent, a regulatory filing showed on Tuesday.

Feb 28 2017

BRIEF-Evotec says will issue 13.1 million new shares to Novo A/S

* Novo A/S becomes new long-term strategic shareholder in Evotec

Feb 09 2017

BRIEF-Evotec and Asahi Kasei Pharma enter drug discovery collaboration

* Entered into an integrated drug discovery collaboration with Asahi Kasei Pharma Corporation Source text for Eikon: Further company coverage:

Jan 19 2017

BRIEF-Evotec sees 2016 core profit more than doubling

* Consolidated group revenues up 37% to eur 120.6 m (9m 2015: eur 88.2 m); base revenues up 30% to eur 105.0 m

Nov 10 2016

BRIEF-Evotec teams up with Oxford University

* Says it and oxford create novel partnership called 'lab282'

Nov 10 2016

More From Around the Web

Earnings vs. Estimates